Innovation-Enabled Market Creation in a Post-Pandemic World: “Campus” Health and the Role of Diagnostic Testing
Student: Riley Ellingsen, 2021-2022
Sponsor: Sense Biodetection Ltd., Oxford, U.K.
Sense Biodetection has developed an entirely new class of molecular diagnostic product. This technology allows PCR-quality testing to take place in a rapid, disposable, instrument-free product, enabling the highest quality diagnostic testing to go anywhere, and change everything. This project will assess how or if this technology may offer clinical and economic benefits to campus-based institutions and workplaces and how or if these segments should be prioritized in a global commercial launch of the technology.